AstraZeneca’s share value plummets after its rejection of £69bn Pfizer bid

 

AstraZeneca lost £6.75bn of its share price value yesterday as the City responded to its rejection of Pfizer’s £69bn “final” takeover bid.

Big shareholders like Axa and Jupiter voiced their disappointment at the British company’s refusal to open discussions after Pfizer upped its offer price late on Sunday.

Astra’s chairman Leif Johansson rejected the new price of £55 per share yesterday morning and spent the rest of the day touring City investors’ offices to reassure them the company was worth more in the long term as an independent business.

Pfizer declared that its fourth offer – made after a weekend of talks with Astra’s board triggered by a slightly lower bid on Friday night – was “final”, and that it would not go hostile, or make the offer directly to shareholders without the backing of the target company’s directors.

Pfizer called on Astra’s shareholders to urge their board to open talks, but the general mood in the City and in the US, where nearly half of Astra’s investors are based, was that the deal would not happen by next Monday’s deadline. That was why Astra’s share price tumbled 11 per cent to £42.87 by the end of the day. Pfizer’s shares gained 1 per cent to $29.44 in late New York trading.

After Monday, Pfizer has to wait another six months before launching another bid.

Axa, which owns about 5 per cent of Astra, said it was “very disappointed” by the UK company’s behaviour, declaring it was “not in shareholders’ interests”.

Jupiter Asset Management said it too was “disappointed”. Other investors speaking on condition of anonymity said they were also irritated by the Astra board’s intransigence. One said: “We believed it would be enough for AstraZeneca to at least start engaging with Pfizer, which is something we have told them they should be doing. The latest bid is within shot of being a good price for the company.”

Some investors pointed out that the price was attractive when set against the historic value of Astra’s shares. Astra responded by arguing that the company was on the cusp of a major transformation which rendered its previous share performance irrelevant.

One key element of the latest bid that attracted some shareholders was the increase in the cash element of the offer to 45 per cent of the price rather than the 30 per cent at which the bidding started.

However, the latest offer still meant shareholders would have had to accept 55 per cent of the proceeds in shares of a business with decidedly risky prospects. That was a point raised by other investors.

Aberdeen Asset Management said it was a “big supporter” of the AstraZeneca management but said it wanted the two sides to keep talking. “There is a lot more to this deal than just price,” said Aberdeen’s fund manager Anne Richards.

Pfizer had to convince shareholders they would be able to reduce the “high-level risk” of disruption to the business both before and after the deal.

Standard Life said the price was “some way short” of being the knockout bid the markets had expected.

The major Swedish shareholder, Investor AB, was also said to be strongly behind the decision to reject the deal. Last week, Investor AB spoke of how it invests for the long term in its companies, and was a big believer in the way Astra has turned around its business in recent years.

For the Government, the deal’s apparent demise removes a potential embarrassment as Labour has made great play of the Coalition’s reluctance to interfere with a deal that was likely to cost UK research jobs.

David Cameron repeated his view that “this is a matter for the companies to resolve themselves”, although the shadow Business Minister, Chuka Umunna, welcomed the bid’s rejection.

Aberdeen’s Ms Richards pointed out that the deal posed a dilemma for fund managers representing a wide range of shareholders’ opinions. “Some will be wanting us just to run their money and achieve the best price, but other clients feel pharmaceuticals is such a critical part of the UK economy that this deal should not happen at all. It is important for us to look at all these issues.”

For the personal finances of Astra chief Pascal Soriot, the demise of a takeover would see him kiss goodbye to a £7.5m windfall – representing the amount his personal shareholding would profit. “He has put his money where his mouth is on this decision,” said one member of the AstraZeneca camp.

Life and Style
A teenager boy wakes up.
life
Life and Style
tech
Arts and Entertainment
Critics say Kipling showed loathing for India's primitive villagers in The Jungle Book
filmChristopher Walken, Bill Murray, Scarlett Johanssen Idris Elba, Andy Serkis, Benedict Cumberbatch, Cate Blanchett and Christian Bale
Life and Style
food + drink
PROMOTED VIDEO
Life and Style
Playing to win: for Tanith Carey, pictured with Lily, right, and Clio, even simple games had to have an educational purpose
lifeTanith Carey explains what made her take her foot off the gas
Arts and Entertainment
A still from Duncan Campbell's hour-long film 'It for Others'
Turner Prize 2014
News
i100
Arts and Entertainment
Tony Hadley in a scene from ‘Soul Boys Of The Western World’
musicSpandau Ballet are back together - on stage and screen
Arts and Entertainment
From left to right: Ed Stoppard as Brian Epstein, Sheridan Smith as Cilla Black and Elliott Cowan as George Martin in 'Cilla'
tvCilla review: A poignant ending to mini-series
News
i100
Life and Style
Bearing up: Sebastian Flyte with his teddy Aloysius in Brideshead Revisited
lifePhilippa Perry explains why a third of students take a bear to uni
Arts and Entertainment
Sir Alan Sugar appearing in a shot from Apprentice which was used in a Cassette Boy mashup
artsA judge will rule if pieces are funny enough to be classed as parodies
News
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Trust Accountant - Kent

NEGOTIABLE: Austen Lloyd: TRUST ACCOUNTANT - KENTIf you are a Chartered Accou...

Graduate Recruitment Consultant - 2013/14 Grads - No Exp Needed

£18000 - £20000 per annum + OTE £30000: SThree: SThree are a global FTSE 250 b...

Law Costs

Highly Competitive Salary: Austen Lloyd: CITY - Law Costs Draftsperson - NICHE...

SQL Developer (Stored Procedures) - Hertfordshire/Middlesex

£300 - £330 per day: Ashdown Group: SQL Developer (Stored Procedures) Watford...

Day In a Page

Isis is an hour from Baghdad, the Iraq army has little chance against it, and air strikes won't help

Isis an hour away from Baghdad -

and with no sign of Iraq army being able to make a successful counter-attack
Turner Prize 2014 is frustratingly timid

Turner Prize 2014 is frustratingly timid

The exhibition nods to rich and potentially brilliant ideas, but steps back
Last chance to see: Half the world’s animals have disappeared over the last 40 years

Last chance to see...

The Earth’s animal wildlife population has halved in 40 years
So here's why teenagers are always grumpy - and it's not what you think

Truth behind teens' grumpiness

Early school hours mess with their biological clocks
Why can no one stop hackers putting celebrities' private photos online?

Hacked photos: the third wave

Why can no one stop hackers putting celebrities' private photos online?
Royal Ballet star dubbed 'Charlize Theron in pointe shoes' takes on Manon

Homegrown ballerina is on the rise

Royal Ballet star Melissa Hamilton is about to tackle the role of Manon
Education, eduction, education? Our growing fascination with what really goes on in school

Education, education, education

TV documentaries filmed in classrooms are now a genre in their own right
It’s reasonable to negotiate with the likes of Isis, so why don’t we do it and save lives?

It’s perfectly reasonable to negotiate with villains like Isis

So why don’t we do it and save some lives?
This man just ran a marathon in under 2 hours 3 minutes. Is a 2-hour race in sight?

Is a sub-2-hour race now within sight?

Dennis Kimetto breaks marathon record
We shall not be moved, say Stratford's single parents fighting eviction

Inside the E15 'occupation'

We shall not be moved, say Stratford single parents
Air strikes alone will fail to stop Isis

Air strikes alone will fail to stop Isis

Talks between all touched by the crisis in Syria and Iraq can achieve as much as the Tornadoes, says Patrick Cockburn
Nadhim Zahawi: From a refugee on welfare to the heart of No 10

Nadhim Zahawi: From a refugee on welfare to the heart of No 10

The Tory MP speaks for the first time about the devastating effect of his father's bankruptcy
Witches: A history of misogyny

Witches: A history of misogyny

The sexist abuse that haunts modern life is nothing new: women have been 'trolled' in art for 500 years
Shona Rhimes interview: Meet the most powerful woman in US television

Meet the most powerful woman in US television

Writer and producer of shows like Grey's Anatomy, Shonda Rhimes now has her own evening of primetime TV – but she’s taking it in her stride
'Before They Pass Away': Endangered communities photographed 'like Kate Moss'

Endangered communities photographed 'like Kate Moss'

Jimmy Nelson travelled the world to photograph 35 threatened tribes in an unashamedly glamorous style